Search for: "PAR PHARMACEUTICALS"
Results 181 - 200
of 303
Sort by Relevance
|
Sort by Date
14 Aug 2011, 9:59 pm
Par Pharmaceutical Inc. et al. 1:11-cv-00705; filed August 10, 2011 in the District Court of Delaware • Plaintiffs: Avanir Pharmaceuticals Inc.; Avanir Holding Company; Center for Neurologic Study • Defendants: Par Pharmaceutical Inc.; Par Pharmaceutical Companies Inc. [read post]
13 Jul 2011, 3:04 am
(The SPC Blog) Doha+10: On November 14, 2011, a meeting at WIPO in Geneva to discuss the Doha Declaration (KEI) Docs at BIO: Session on IP challenges for personalised medicine (Patent Docs) France to reform its pharmaceutical regulatory system… with possible global implications! [read post]
7 Jul 2011, 1:57 pm
Par Pharmaceutical, No. 2011–1391 (Fed. [read post]
1 Jul 2011, 7:01 am
Beximco Pharmaceuticals to the practice of forums specializing in Islamic finance dispute resolution. [read post]
1 Jul 2011, 7:01 am
Beximco Pharmaceuticals to the practice of forums specializing in Islamic finance dispute resolution. [read post]
15 Jun 2011, 4:56 am
Par Pharmaceutical, Inc. [read post]
12 Jun 2011, 9:17 pm
.; Par Pharmaceutical Inc. [read post]
31 May 2011, 8:38 pm
Novo Nordisk (Orange Book Blog) Silenor (Doxepin) – US: Somaxon files patent infringement lawsuit against Par Pharmaceuticals over bid to market generic Silenor (GenericsWeb) Strattera (Atomoxetine) – US: Eli Lilly files patent infringement complaint against Zydus in response to Para IV certification (Patent Docs) Zemplar (Paricalcitol) – US: Abbott Lab’s files patent infringement complaint against Sandoz in response to Para IV certification (Patent Docs)… [read post]
5 May 2011, 1:49 pm
Every pharmaceutical mass tort, and a lot of cases that aren’t pattern litigation, prompt the targeted defendants to issue one or more “litigation holds” to stop the routine destruction of potentially discoverable information (both paper and electronic) to avoid the plaintiffs trying to accuse them of spoliation of evidence.One of the opening rituals of many mass torts is the plaintiff side typically rushing into court to get the court formally to order the… [read post]
4 May 2011, 10:36 am
4 May 2011, 12:33 am
To the surprise of absolutely no one, the U.S. has again placed Canada on its Special 301 Priority Watch List, implausibly claiming that Canada's intellectual property laws are seriously deficient and on par with countries such as China and Russia. [read post]
24 Apr 2011, 9:30 pm
By James DeGiulio -- Pozen Secures Injunction Blocking Par's Generic Treximet Earlier this month, Pozen obtained a preliminary injunction blocking Par Pharmaceutical from marketing a generic version of Pozen's migraine drug Treximet until an infringement suit over the drug is resolved. [read post]
19 Apr 2011, 5:04 pm
Highlights this week included: Aricept (Donepezil HCI) – US: Lawsuit alleges false marking based on Orange Book ‘advertising’: Pharmaceutical Technologies v Eisai (FDA Law Blog) (Patent Docs) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
6 Apr 2011, 12:18 am
Highlights this week included: India firm on ‘NO’ to data exclusivity (SiNApSE) (Generic Pharmaceuticals and IP) (Spicy IP) (Spicy IP) US: CAFC hears oral arguments on patentability of DNA claims: American Molecular Pathology, et. al, v. [read post]
5 Apr 2011, 2:35 pm
Par Pharmaceutical, Inc. [read post]
29 Mar 2011, 9:19 pm
Merck (Kluwer Patent Blog) Keppra (Levetiracetam) – US: Orange Book patent listing precipitates DJ action to trigger generic Keppra XR 180-day exclusivity forfeiture: Par Pharmaceutical v UCB et al (FDA Law Blog) (Patent Docs) Naropin (Ropivacaine) – US: Judge O’Malley in dissent: Patent assignments should be a matter of state law: Abraxis BioScience v. [read post]
28 Mar 2011, 2:42 pm
Karst – Late last week, Par Pharmaceutical, Inc. [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
6 Feb 2011, 9:34 pm
• Defendants: Par Pharmaceutical Inc.; Par Pharmaceutical Companies Inc. [read post]
3 Jan 2011, 9:45 pm
Nursing Homes: PATIENTS SUFFER SUB-PAR CARE AT CALIFORNIA FACILITIES, CLASS ACTION SAYS, Valentine v. [read post]
